CLINICAL RESEARCH
Causal relationship between inflammatory bowel disease and cardiovascular disease: a two-sample Mendelian randomized study
More details
Hide details
1
Department of Cardiovascular Diseases, First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China
2
First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China
3
Henan University of Chinese Medicine Department of Traditional Chinese Medicine, Henan Provincial People's Hospital, China
These authors had equal contribution to this work
Submission date: 2024-11-15
Final revision date: 2025-04-24
Acceptance date: 2025-04-25
Online publication date: 2025-05-27
Corresponding author
Yongxia Wang
Department of Cardiovascular Diseases, First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and ulcerative colitis (UC). Epidemiological studies have found that patients with IBD are more likely to suffer from cardiovascular diseases (CVDs) than the general population. However, so far, no exact causal association has been demonstrated between IBD and CVDs, and more research is needed to clarify this relationship.
Material and methods:
The two-sample Mendelian randomization (MR) method was used to explore the causal effect of IBD on CVDs. The exposure factor was IBD, including CD and UC. The outcome was CVDs, including chronic heart failure, atrial fibrillation, coronary heart disease, myocardial infarction and hypertension. The single nucleotide polymorphisms (SNPs) are all from the FinnGen genome-wide association study sample database. The CD samples included 210,300 controls and 807 cases, and the UC samples included 215,806 controls and 2701 cases. The samples included are all European samples. SNPs associated with Crohn’s disease and ulcerative colitis were extracted from the IEUGWAS database and quality control and screening were carried out. Inverse variance weighted (IVW), MR-Egger, weighted median and other methods were used to study the causal relationship between them and CVDs. Finally, Cochrane’s Q test, MR-Egger and the leave-one method were used for sensitivity analysis.
Results:
In this study, 4 SNPs strongly associated with Crohn’s disease and 12 SNPs strongly associated with ulcerative colitis were screened. The IVW method of genetic prediction revealed a positive correlation between Crohn’s disease and the risk of chronic heart failure (OR =1.02; 95% CI: 1.00–1.04), and there was a positive correlation between ulcerative colitis and the risk of chronic heart failure (OR = 1.03; 95% CI:1.00–1.06). IVW, MR-Egger and weighted median showed that Crohn’s disease and ulcerative colitis were not associated with the risk of atrial fibrillation, coronary heart disease, myocardial infarction or hypertension. Sensitivity analysis showed that the results are robust.
Conclusions:
Crohn’s disease and ulcerative colitis are associated with an increased risk of chronic heart failure, but they are not associated with the risk of other CVDs.
REFERENCES (28)
1.
Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-17.
2.
GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5: 17-30.
3.
Joseph P, Leong D, McKee M, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res 2017; 121: 677-94.
4.
Lykowska-Szuber L, Rychter AM, Dudek M, et al. What links an increased cardiovascular risk and inflammatory bowel disease? A narrative review. Nutrients 2021; 13: 2661.
5.
Lamina C. Mendelian randomization: principles and its usage in Lp(a) research. Atherosclerosis 2022; 349: 36-41.
6.
Gala H, Tomlinson I. The use of Mendelian randomisation to identify causal cancer risk factors: promise and limitations. J Pathol 2020; 250: 541-54.
7.
Sun Y, Hou P. The relationship between blood pressure and risk of atrial fibrillation: a combined and sex-stratified Mendelian randomization study. Arch Med Sci 2024; 20: 2072-6.
8.
Ference BA, Holmes MV, Smith GD. Using Mendelian randomization to improve the design of randomized trials. Cold Spring Harb Perspect Med 2021; 11: a040980.
9.
Zeng X, Juaiti M, Tang Y, et al. Circulating micronutrients and risk of stroke: a Mendelian randomisation and cross-sectional observational study. Arch Med Sci 2024; 20: 2034-8.
10.
Ding L, Chen Q, Liang H, et al. Physical activities and breast cancer: a Mendelian randomization study. Arch Med Sci 2024; 20: 1957-67.
11.
Bowden J, Smith GD, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304-14.
12.
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 2017; 32: 377-89.
13.
Lin Z, Pan I, Pan W. A practical problem with Egger regression in Mendelian randomization. PLoS Genet 2022; 18: e1010166.
14.
Hemani G, Bowden J, Davey SG. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet 2018; 27: R195-208.
15.
Cho Y, Haycock PC, Sanderson E, et al. Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework. Nat Commun 2020; 11: 1010.
16.
Singh N, Bernstein CN. Environmental risk factors for inflammatory bowel disease. United European Gastroenterol J 2022; 10: 1047-53.
17.
Luo J, Xu Z, Noordam R, et al. Depression and inflammatory bowel disease: a bidirectional two-sample Mendelian randomization study. J Crohns Colitis 2022; 16: 633-42.
18.
Freuer D, Linseisen J, Meisinger C. Association between inflammatory bowel disease and both psoriasis and psoriatic arthritis: a bidirectional 2-sample Mendelian randomization study. JAMA Dermatol 2022; 158: 1262-8.
19.
Li Y, Guo J, Cao Z, Wu J. Causal Association between inflammatory bowel disease and psoriasis: a two-sample Bidirectional Mendelian randomization study. Front Immunol 2022; 13: 916645.
20.
Kristensen SL, Ahlehoff O, Lindhardsen J, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death: a Danish nationwide cohort study. PLoS One 2013; 8: e56944.
21.
Chen B, Collen LV, Mowat C, et al. Inflammatory bowel disease and cardiovascular diseases. Am J Med 2022; 135: 1453-60.
22.
Nunez P, Mateo SG, Quera R, Gomollón F. Inflammatory bowel disease and the risk of cardiovascular diseases. Gastroenterol Hepatol 2021; 44: 236-42.
23.
Wu H, Hu T, Hao H, et al. Inflammatory bowel disease and cardiovascular diseases: a concise review. Eur Heart J Open 2022; 2: oeab029.
24.
Jaiswal V, Batra N, Dagar M, et al. Inflammatory bowel disease and associated cardiovascular disease outcomes: a systematic review. Medicine (Baltimore) 2023; 102: e32775.
25.
Qiu X, Hou C, Yang Z, et al. Inflammatory bowel disease and risk of coronary heart disease: a Mendelian randomization study. Wien Klin Wochenschr 2022; 134: 779-87.
26.
Chen L, Jiang C. Does Chronic intestinal inflammation promote atrial fibrillation: a Mendelian randomization study with populations of European ancestry. Front Cardiovasc Med 2021; 8: 641291.
27.
Wu K, Li A, Liu L, et al. Inflammatory bowel disease and cardiovascular disease: a two-sample Mendelian randomization analysis. Front Cardiovasc Med 2022; 9: 927120.
28.
Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods 2019; 10: 486-96.